Allogeneic Hematopoietic Cell Transplantation for Congenital Athymia: A Nationwide Retrospective Study in Japan
Journal of Clinical Immunology · 28.03.2026 · 46 (1)
DOI: 10.1007/s10875-026-02008-y ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Clinical Immunology, online erschienen am 28.03.2026. Verfasst von Tsubasa Nishinosono und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8560, Japan. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nagoya University.
Abstract (Originalsprache)
Purpose
Congenital athymia is a life-threatening condition characterized by thymic absence and profound T-cell immunodeficiency. Thymus implantation is the definitive treatment, but its availability is limited. This study aimed to evaluate the outcomes of hematopoietic cell transplantation (HCT) as an alternative therapy.
Methods
A nationwide, multicenter, retrospective study analyzed nine patients who underwent allogeneic HCT between 2000 and 2024 in Japan. Overall survival (OS) was estimated using the Kaplan–Meier method, and the cumulative incidence of immunodeficiency-related mortality was assessed using Gray’s test.
Results
Among the nine patients, eight (89%) received umbilical cord blood, and one (11%) received related peripheral blood. Seven patients (78%) underwent transplantation without conditioning. Engraftment with T-cell recovery was achieved in six patients (67%), with a median CD4 + T-cell count of 0.352 × 10 9 /L (range, 0.216–1.578 × 10 9 /L) at the last follow-up. Acute graft-versus-host disease (GVHD) occurred in five patients (56%), all with Grade I–II skin involvement. No chronic GVHD was observed. The one-year OS rate was 66.7% (95% confidence interval: 28.2%–87.8%). Overall, six patients (67%) died: three early deaths within the first month from infections, and three late deaths beyond 1 year from congenital comorbidities. HCT before six months of age was associated with significantly lower immunodeficiency-related mortality ( p = 0.02).
Conclusion
HCT can allow immune reconstitution in congenital athymia, although long-term survival is affected by comorbidities. Early diagnosis and timely intervention are crucial in managing this condition. HCT can be a restricted alternative therapy for patients ineligible for thymus implantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8560, Japan.
- Department of Pediatric Critical Care, Shizuoka Children's Hospital, Shizuoka, Japan.
- Department of Pediatrics, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8560, Japan. hideki-muramatsu@med.nagoya-u.ac.jp.
- Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
- Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan.
- Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan.
Förderung
- Nagoya University
Zitieren
APA
Nishinosono, T., Muramatsu, H., Wakamatsu, M., Sonoda, M., Eguchi, K., Kawaguchi, K., Yamamoto, T., Kudo, T., Kajiwara, M., Ishimura, M., & Takahashi, Y. (2026). Allogeneic Hematopoietic Cell Transplantation for Congenital Athymia: A Nationwide Retrospective Study in Japan. Journal of Clinical Immunology, 46(1). https://doi.org/10.1007/s10875-026-02008-y
Vancouver
Nishinosono T, Muramatsu H, Wakamatsu M, Sonoda M, Eguchi K, Kawaguchi K, et al. Allogeneic Hematopoietic Cell Transplantation for Congenital Athymia: A Nationwide Retrospective Study in Japan. Journal of Clinical Immunology. 2026;46(1). doi:10.1007/s10875-026-02008-y
BibTeX
@article{Nishinosono2026,
author = {Nishinosono, Tsubasa and Muramatsu, Hideki and Wakamatsu, Manabu and Sonoda, Motoshi and Eguchi, Katsuhide and Kawaguchi, Koji and Yamamoto, Takeshi and Kudo, Takahiro and Kajiwara, Michiko and Ishimura, Masataka and Takahashi, Yoshiyuki},
title = {Allogeneic Hematopoietic Cell Transplantation for Congenital Athymia: A Nationwide Retrospective Study in Japan},
journal = {Journal of Clinical Immunology},
year = {2026},
volume = {46},
number = {1},
doi = {10.1007/s10875-026-02008-y}
}
EUVIMED